Skip to main content

Advertisement

Log in

Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To explore the relationships between macular thickness and the plasma concentrations of homocysteine, vitamin B12, folate, and other known risk factors for patients with diabetes without diabetic macular edema (DME).

Methods

Fasting venous blood samples were collected from 252 subjects (126 relatively healthy subjects with type 2 diabetes without diabetic macular edema and 126 age- and gender-matched controls). Measurement of macular thickness and volume was performed for those subjects using SD-OCT. The plasma concentrations of homocysteine, vitamin B12, folate, and other known risk factors were analyzed in all the patients and controls using multiple linear regression models.

Results

An increase in the serum levels of homocysteine was present within patients with type 2 diabetes compared to healthy individuals. The mean total plasma homocysteine levels were associated with a greater central subfield macular thickness (CSMT), average macular thickness (AMT), and average macular volume (AMV) in patients with type 2 diabetes without DME, after adjusting for age, sex, duration of diabetes, and HbA1c. Each 1 mmol/L increase in tHcy level was associated with a 6.57 µm greater CSMT (95% confidence interval [CI] 1.78, 11.36), a 4.51 µm greater AMT (95% CI 1.05, 7.98), and a 4.72 mm3 greater AMV (95% CI 1.23, 8.21).

Conclusions

Higher homocysteine levels were associated with an increased CSMT, AMT, and AMV in diabetic patients without DME. This link may indicate that patients with type 2 diabetes with increased levels of plasma tHcy are more prone to develop a clinical manifestation of DME.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249–1257

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ko F, Vitale S, Chou CF, Cotch MF, Saaddine J, Friedman DS (2012) Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999–2002 and 2005–2008. JAMA 308:2361–2368

    Article  CAS  PubMed  Google Scholar 

  3. Jia WP, Pang C, Chen L et al (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50:286–292

    Article  CAS  PubMed  Google Scholar 

  4. Ikram MK, Cheung CY, Lorenzi M et al (2013) Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care 36:750–759

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M (2013) Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4:290–294

    Article  PubMed  PubMed Central  Google Scholar 

  6. Klein R, Klein BE, Moss SE (1984) Visual impairment in diabetes. Ophthalmology 91:1–9

    Article  CAS  PubMed  Google Scholar 

  7. Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564

    Article  PubMed  PubMed Central  Google Scholar 

  8. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) The Wisconsin epidemiologic study of diabetic retinopathy XV. The long-term incidence of macular edema. Ophthalmology 102:7–16

    Article  CAS  PubMed  Google Scholar 

  9. Dong N, Xu B, Chu L, Tang X (2015) Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PLoS ONE 10:e0125329

    Article  PubMed  PubMed Central  Google Scholar 

  10. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512–523

    Article  CAS  PubMed  Google Scholar 

  11. Navaratna D, McGuire PG, Menicucci G, Das A (2007) Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56:2380–2387

    Article  CAS  PubMed  Google Scholar 

  12. McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U (2009) Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 116(1778–1787):e1

    Google Scholar 

  13. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536–545

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113

    Article  CAS  PubMed  Google Scholar 

  15. Magné J, Huneau JF, Borderie D, Mathé V, Bos C, Mariotti F (2015) Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia. Amino Acids 47:1975–1982

    Article  PubMed  Google Scholar 

  16. Wang XC, Sun WT, Yu CM et al (2015) ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels. Atherosclerosis 242:191–198

    Article  CAS  PubMed  Google Scholar 

  17. Lai WK, Kan MY (2015) Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 67:1–12

    Article  CAS  PubMed  Google Scholar 

  18. Eren E, Ellidag HY, Aydin O, Yılmaz N (2014) Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur. J Clin Diagn Res 8:CE01–CE04

    PubMed  PubMed Central  Google Scholar 

  19. Aydin E, Demir HD, Ozyurt H, Etikan I (2008) Association of plasma homocysteine and macular edema in type 2 diabetes mellitus. Eur J Ophthalmol 18:226–232

    Article  CAS  PubMed  Google Scholar 

  20. Klein BE, Knudtson MD, Tsai MY, Klein R (2009) The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 127:1175–1182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Li J, Zhang H, Shi M, Yan L, Xie M (2014) Homocysteine is linked to macular edema in type 2 diabetes. Curr Eye Res 39:730–735

    Article  PubMed  Google Scholar 

  22. Zhang J, Ma J, Zhou N, Zhang B, An J (2015) Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies. Med Sci Monit 21:929–936

    Article  PubMed  PubMed Central  Google Scholar 

  23. Chen S, Wang B, Dong N, Ren X, Zhang T, Xiao L (2014) Macular measurements using spectral-domain optical coherence tomography in Chinese myopic children. Invest Ophthalmol Vis Sci 55:7410–7416

    Article  PubMed  Google Scholar 

  24. Dong N, Wang B, Chu L, Xiao L (2013) Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population. Curr Eye Res 38:1153–1158

    Article  CAS  PubMed  Google Scholar 

  25. Dong N, Xu B, Tang X (2014) Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population. Invest Ophthalmol Vis Sci 55:4057–4062

    Article  CAS  PubMed  Google Scholar 

  26. Ubbink JB, Hayward Vermaak WJ, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441–446

    Article  CAS  PubMed  Google Scholar 

  27. Brazionis L, Rowley K Sr, Itsiopoulos C, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56

    Article  CAS  PubMed  Google Scholar 

  28. Hoogeveen EK, Kostense PJ, Eysink PE et al (2000) Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med 160:2984–2990

    Article  CAS  PubMed  Google Scholar 

  29. Huang EJ, Kuo WW, Chen YJ et al (2006) Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 366:293–298

    Article  CAS  PubMed  Google Scholar 

  30. Gupta P, Sidhartha E, Tham YC et al (2013) Determinants of macular thickness using spectral domain optical coherence tomography in healthy eyes: the Singapore Chinese Eye study. Invest Ophthalmol Vis Sci 54:7968–7976

    Article  CAS  PubMed  Google Scholar 

  31. Diabetic Retinopathy Clinical Research Network, Bressler NM, Miller KM et al (2012) Observational study of subclinical diabetic macular edema. Eye (Lond) 26:833–840

    Article  Google Scholar 

  32. Bhavsar KV, Subramanian ML (2011) Risk factors for progression of subclinical diabetic macular oedema. Br J Ophthalmol 95:671–674

    Article  PubMed  Google Scholar 

  33. Emoto M, Kanda H, Shoji T et al (2001) Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24:533–538

    Article  CAS  PubMed  Google Scholar 

  34. Passaro A, Calzoni F, Volpato S et al (2003) Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med 254:264–271

    Article  CAS  PubMed  Google Scholar 

  35. Ren H, Mu J, Ma J et al (2016) Selenium inhibits homocysteine-induced endothelial dysfunction and apoptosis via activation of AKT. Cell Physiol Biochem 38:871–882

    Article  CAS  PubMed  Google Scholar 

  36. Gundogan FC, Yolcu U, Akay F, Ilhan A, Ozge G, Uzun S (2016) Diabetic macular edema. Pak J Med Sci 32:505–510

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the support of Xiao Lin Chair in Department of Ophthalmology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin Tang.

Ethics declarations

Conflict of interest

No potential conflicts of interest relevant to this article were reported.

Ethical approval

The study was approved by the Ethics Committee of Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China, and was performed in accordance with the Declaration of Helsinki.

Informed consent

Each subject received a detailed information leaflet and provided informed written consent before participation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, N., Shi, H. & Tang, X. Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema. Int Ophthalmol 38, 737–746 (2018). https://doi.org/10.1007/s10792-017-0528-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0528-0

Keywords

Navigation